Atossa Therapeutics Inc Stock Performance
as on March 28, 2026 at 6:56 am IST
Day's Low
Day's High
$4.60$4.92
2.54%
Downside
4.24%
Upside
52 Week's Low
52 Week's High
$3.76$19.3520.34%
Downside
309.96%
Upside
Atossa Therapeutics Inc share price movements today
- Previous Close
- $4.71
- Open
- $4.60
- Volume
- 263.1K
- Day's Low - High
- $4.60 - $4.92
- 52 Week Low - High
- $3.76 - $19.35
Atossa Therapeutics Inc Historical Returns
- 1 Month Return
- + 6.55 %
- 3 Month Return
- -52.24 %
- 1 Year Return
- -54.8 %
- 3 Year Return
- -54.06 %
- 5 Year Return
- -85.43 %
Atossa Therapeutics Inc Stock Fundamentals & Key Indicators
Check Atossa Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$40.6M
EPS (TTM)
-4.31
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-37.1M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-62.75%
Atossa Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Atossa Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $40.6M | -85.43% | NA | 0.00% | |
| BUY | $43.5B | 132.92% | 140.84 | 8.45% | |
| BUY | $115.2B | 101.77% | 29.58 | 32.94% | |
| NA | $31.8B | NA | 112.58 | 5.37% | |
| BUY | $80.0B | 54.69% | 18.25 | 31.41% |
Stock Returns calculator for Atossa Therapeutics Inc Stock including INR - Dollar returns
The Atossa Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atossa Therapeutics Inc investment value today
Current value as on today
₹55,839
Returns
Returns from Atossa Therapeutics Inc Stock
Dollar Returns*
₹10,628 (+10.63%)
Analyst Recommendation on Atossa Therapeutics Inc Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Atossa Therapeutics Inc. Average target price of $43.75
Atossa Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Atossa Therapeutics Inc.
What analysts predicted
89.21%UPSIDE
Target Price
$43.75
Current Price
$4.72
Analyzed by
10 Analysts
Target
$43.75
Atossa Therapeutics Inc target price $43.75, a slight upside of 89.21% compared to current price of $4.72. According to 10 analysts rating.
Atossa Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for Atossa Therapeutics Inc Stock has decreased by -82% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Atossa Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Atossa Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Atossa Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Atossa Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on Atossa Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 122.4%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 73.0%
NEGATIVE IMPACTPrice Dip
In the last 7 days, ATOS stock has moved down by -11.4%
About Atossa Therapeutics Inc
What is Atos?
Atossa Therapeutics, Inc., popularly called Atos, is a clinical-stage biopharmaceutical company focused on developing innovative treatments in oncology, particularly for breast cancer. It was founded in 2008 and is headquartered in Seattle, Washington. The company was formerly known as Atossa Genetics Inc. before rebranding to Atossa Therapeutics, Inc. in January 2020.
What does Atos do?
Atossa develops targeted therapies for breast cancer and related conditions with a focus on areas of unmet medical need. Its lead candidate, oral (Z)-endoxifen, is an active metabolite of tamoxifen currently in Phase II clinical trials for breast cancer treatment and prevention. The company is also advancing immunotherapy programs, including chimeric antigen receptor (CAR) therapies, to expand its pipeline into other oncology areas.
Atos Products and Programs
| Products/Programs | Description |
| Oral (Z)-Endoxifen | Phase II-stage drug for treatment and prevention of hormone-receptor positive breast cancer |
| Immunotherapy Programs | Development of CAR-based therapies to target cancerous cells |
| Oncology R&D | Focus on novel, targeted treatments for breast cancer and related indications |
| Clinical Trials | Multiple Phase I/II trials evaluating safety and efficacy of pipeline therapies |
| Organisation | Atossa Therapeutics Inc |
| Headquarters | 107 Spring Street, Seattle, WA, United States, 98104 |
| Industry | Health Technology |
| CEO | Dr. Steven C. Quay FCAP, M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Atossa Therapeutics Inc
Name | Title |
|---|---|
Ms. Delly Behen P.H.R. | Senior Vice President of Business Operations |
Dr. Richard Graydon M.D., Ph.D. | Interim Chief Medical Officer |
Dr. Steven C. Quay FCAP, M.D., Ph.D. | Chairman, CEO & President |
Mr. Mark Daniel CPA | Chief Financial Officer |
Ms. Janet Rose Rea MSPH, RAC | Senior Vice President of Research & Development |
FAQs
What is Atossa Therapeutics Inc share price today?
Atossa Therapeutics Inc share price today is $4.72 as on at the close of the market. Atossa Therapeutics Inc share today touched a day high of $4.92 and a low of $4.6.
What is the 52 week high and 52 week low for Atossa Therapeutics Inc share?
Atossa Therapeutics Inc share touched a 52 week high of $19.35 on and a 52 week low of $3.76 on . Atossa Therapeutics Inc stock price today i.e. is closed at $4.72,which is 75.61% down from its 52 week high and 25.53% up from its 52 week low.
What is Atossa Therapeutics Inc's market capitalisation today?
Atossa Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Atossa Therapeutics Inc Stock (ATOS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Atossa Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Atossa Therapeutics Inc Shares that will get you 0.3178 shares as per Atossa Therapeutics Inc share price of $4.72 per share as on March 28, 2026 at 1:26 am IST.
What is the minimum amount required to buy Atossa Therapeutics Inc Stock (ATOS) from India?
Indian investors can start investing in Atossa Therapeutics Inc (ATOS) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.30 in Atossa Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atossa Therapeutics Inc share’s latest price of $4.72 as on March 28, 2026 at 1:26 am IST, you will get 2.1186 shares of Atossa Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Atossa Therapeutics Inc has given to Indian investors in the last 5 years?
Atossa Therapeutics Inc stock has given -85.43% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?